Mumbai, Aug. 13 -- Thyrocare Technologies announced that Docon Technologies, promoter of the company, has sold 1,57,69,696 equity shares (9.90% stake) of the company through market trades today, i.e. 13 August 2026.

Published by HT Digital Content Services with permission from Capital Market....